Skip to main content
Clinical Trials/ITMCTR2200006507
ITMCTR2200006507
Not yet recruiting
Phase 1

Efficacy of electroacupuncture in the treatment of peripheral neuropathy caused by Utidelon: a randomized controlled study

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Cancer
Sponsor
Zhejiang Cancer Hospital
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • ? According to the diagnostic criteria of CIPN, recent use of utidelon chemotherapy resulted in grade I and above peripheral neuropathy; ? Age 18\-70 years old; ? Have the ability of daily living, Karnofsky function score \> 70, and can cooperate independently to complete all treatments; ? No severe diseases such as gravity center, liver, brain and kidney, and no serious mental diseases; ? Voluntarily participate and sign informed consent.

Exclusion Criteria

  • ? Those who do not meet the above requirements; ? Pregnant women, or combined with other serious diseases, end\-stage cachexia, etc; ? Peripheral neuropathy caused by other diseases; ? Those who do not cooperate with the treatment or are participating in other acupuncture or drug clinical trials; ? Those who do not agree to participate in the clinical trial or cannot follow up on time.

Outcomes

Primary Outcomes

Not specified

Similar Trials